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Abstract
Background: The availability of reliable point-of-care tests for malaria has heralded a paradigm shift in the management of
febrile illnesses away from presumptive antimalarial therapy. In the absence of a definitive diagnosis, health care providers
are more likely to prescribe empirical antimicrobials to those who test negative for malaria. To improve management and
guide further test development, better understanding is needed of the true causative agents and their geographic variability.
Methods: A systematic review of published literature was undertaken to characterise the spectrum of pathogens causing
non-malaria febrile illness in Africa (1980–2015). Literature searches were conducted in English and French languages in six
databases: MEDLINE, EMBASE, Global Health (CABI), WHO Global Health Library, PASCAL, and Bulletin de la Société Française
de Parasitologie (BDSP). Selection criteria included reporting on an infection or infections with a confirmed diagnosis, defined
as pathogens detected in or cultured from samples from normally sterile sites, or serological evidence of current or past
infection. A number of published articles (rather than incidence or prevalence) reporting a given pathogen were presented.
Results: A total of 16,523 records from 48 African countries were screened, of which 1065 (6.4%) met selection criteria.
Bacterial infections were reported in 564 (53.0%) records, viral infections in 374 (35.1%), parasitic infections in 47 (4.4%),
fungal infections in nine (0.8%), and 71 (6.7%) publications reported more than one pathogen group. Age range of the
study population was not specified in 233 (21.9%) publications. Staphylococcus aureus (18.2%), non-typhoidal
Salmonella (17.3%), and Escherichia coli (15.4%) were the commonly reported bacterial infections whereas Rift Valley
fever virus (7.4%), yellow fever virus (7.0%), and Ebola virus (6.7%) were the most commonly reported viral infections.
Dengue virus infection, previously not thought to be widespread in Africa, was reported in 54 (5.1%) of articles.
Conclusions: This review summarises the published reports of non-malaria pathogens that may cause febrile illness in
Africa. As the threat of antimicrobial resistance looms, knowledge of the distribution of infectious agents causing fever
should facilitate priority setting in the development of new diagnostic tools and improved antimicrobial stewardship.
Trial registration: PROSPERO, CRD42016049281
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Background
The introduction of malaria antigen-based rapid diagnostic
tests (RDTs) has heralded a paradigm shift in the manage-
ment of febrile illnesses in malaria-endemic countries. His-
torically, malaria was considered by default the principal
cause of fever, and presumptive antimalarial therapy was
widespread policy and practice [1]. In 2010, the World
Health Organization (WHO) amended the recommenda-
tion for acute fever case management from presumptive
antimalarial treatment to parasite-based diagnosis for all
populations and endemic areas [1]. While challenges re-
main for malaria RDT implementation, the availability of
relatively simple, reliable, and accessible point-of-care tests
means that it has become more straightforward to rule mal-
aria out of the differential diagnosis.
The “test before treat” approach has demonstrated that
misclassification of much febrile illness had previously led
to an overestimation of malaria incidence [2]. Since the
clinical presentations of febrile episodes are often non-
specific, definitive diagnosis requires an array of laboratory
tests, many unavailable at point of care [3]. Where tests
are used, a large proportion of patients with fever still re-
main undiagnosed. In many African countries, diagnostic
facilities are limited, and surveillance networks are often
clustered around research institutions, leaving wide geo-
graphic swathes with no data on the aetiologies of febrile
illnesses [4]. In the absence of reliable data, health care
providers often resort to prescription of empiric anti-
microbial therapies [5–7], potentially promoting the emer-
gence and spread of antimicrobial resistance (AMR). This
has catapulted the improvement of fever case manage-
ment into the limelight as a global health priority, with a
recent proliferation of articles describing aetiologies of
non-malarial febrile illnesses (NMFI) in low- and middle-
income countries [4, 6, 8–12].
Where reliable diagnostics are lacking, a knowledge of
pathogen distributions may inform judicious empiric
prescription of antimicrobials [13]. Currently, there is a
paucity of information regarding pathogen distribution
for many regions in Africa. Furthermore, there is cur-
rently no consensus on how to report NMFI aetiology
results, making it difficult to view distribution across
time and space. To begin to address this knowledge gap,
a systematic review of published literature from 1980 to
2015 was conducted, and the results were used to gener-
ate an on-line, open-access, interactive map.
Methods
Literature search strategy
The systematic review followed the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses (PRIS
MA) guidelines [14], restricted to articles published from
1980 (estimated date of availability of modern diagnostic
tests, including molecular testing, for infectious diseases)
to 2015 in English and French languages in six data-
bases: MEDLINE, EMBASE, Global Health (CABI) data-
base, WHO Global Health Library, PASCAL, and
Bulletin de la Société Française de Parasitologie (BDSP).
Search terms were specific for pathogens and symptoms,
combined with either “Africa” or individual country
names (Additional file 1, Section 1). This review is regis-
tered with the PROSPERO (registration ID:
CRD42016049281).
Study selection and full-text review
Titles and abstracts, as well as full texts when the ab-
stract did not provide sufficient information, were first
screened for compliance with the inclusion and exclu-
sion criteria (Table 1). One author (JE) independently
applied these criteria to identified studies, and the
screening was quality controlled by comparing results
with a second author (PS) and with colleagues working
on harmonised reviews of articles from other geographic
regions [15].
Data extraction
Data were extracted from selected articles for pre-
defined variables on study design, study location, and
pathogens (Additional file 1, Section 1). When the study
tested for a specific pathogen and did not detect it, that
pathogen was not included in the extracted data. Where
studies identified fever-causing pathogens other than
target pathogens, these were also extracted and included
in the database.
Case definitions
Case definitions were based on laboratory confirmation
of infection; clinical criteria were not included. For this
review, a confirmed diagnosis was defined as bacterial or
fungal isolates detected in or cultured from samples
from normally sterile sites (e.g. blood, cerebrospinal
fluid, arthrocentesis or paracentesis fluid, or virus or
parasite detection in blood or cerebrospinal fluid) or
serological evidence of current or past infection. Where
additional assays were done (PCR, etc.), these were
noted in the database but not used in case definitions
due to heterogeneous reporting standards.
Study type
Studies were categorised into (i) case series, which in-
cluded individual case reports or series of patients with
the same infection; (ii) fever series, where a group of fe-
brile patients was tested for a number of causative
agents and where the total population tested (denomin-
ator) was reported; and (iii) seroprevalence studies, where
serum samples were tested for one pathogen or a panel
of pathogens simultaneously. Details regarding the
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timing of sample collection (e.g. analysis of paired sera)
were not extracted for the seroprevalence studies.
Geographical classification of countries
Countries were classified by sub-region according to
United Nations designations [16]. To assess whether
data may be biased toward sites near to urban areas, the
distance between the study location and nearest major
city was calculated using the Havernsine formula assum-
ing the radius of the earth to be 6371 km available in
pracma package [17] in R software version 3.2.4 (R
Foundation for Statistical Computing, Vienna, Austria)
[18]. The coordinates of cities in Africa were obtained
from the maps package [19], and the nearest major city
to a given study site was defined as a place with a popu-
lation greater than 100,000 persons.
Categorisation of infections
Infections were categorised as bacterial, fungal, parasitic,
or viral and were sub-categorised using an epidemio-
logical definition based on their principal mode of trans-
mission as contact (direct, indirect, droplet, or droplet
nuclei transmission), vector-borne, air-borne, and food-
and/or water-borne. Infections caused by all serotypes of
Salmonella except for Typhi, Paratyphi A, Paratyphi B,
and Paratyphi C were defined as non-typhoidal Salmon-
ella (NTS). Details regarding the categorisation of the
infections are presented in Additional file 2.
Study population
Study populations were grouped into four mutually ex-
clusive categories: neonates (aged < 28 days), infants (1–
12months), children (1–12 years), and older (≥ 13 years).
If a study reported any participants from each age group,
then they were grouped as participants of “all ages”.
Database and on-line interactive map
An on-line database enabled multiple users (JE, PS) in dif-
ferent locations to work on the review database simultan-
eously. Each study site location was geo-coded onto an
on-line interactive map (surveyor), searchable by country,
pathogen, year, and patient age group, and hosted by the
Infectious Diseases Data Observatory (IDDO) [20].
Statistical analyses and risk of bias assessment
The unit of analysis was “published article”. Articles
reporting a given pathogen were categorised by geo-
graphic region, patient age group, pathogen category,
and predominant epidemiologic mode of transmission.
In fever series studies that reported the number of indi-
viduals tested for a given pathogen (the denominator),
the median (range) proportion testing positive was pre-
sented by article. The heterogeneity of study design,
pathogens sought, laboratory methods, reporting, and
limitations in data extraction precluded meta-analysis or
estimation of pathogen prevalence.
The currently available tools for assessing the quality
and risk of bias were not applicable to our review design
[21, 22]. We developed criteria specifically for quality as-
sessment of the studies included in this review (Add-
itional file 3). The risk of bias assessment was based on
available information regarding study design and labora-
tory methods used for the identification of the patho-
gens. Case reports and series were considered to be at a
high risk of bias because they may report atypical pre-
sentations and epidemiological outbreaks. Seropreva-
lence studies were considered to be at moderate risk of
bias as the distinction of acute and past infections de-
pends on sample timing. For fever series, studies using
culture or PCR methods were considered to be at low
risk of bias, those using serological methods at moderate
Table 1 Inclusion and exclusion criteria
Inclusion
criteria
Reporting on pathogens causing fever in human inpatients or outpatients
Studies conducted in the targeted geographical areas
Abstract and full text available in English or French
Samples tested from normally sterile sites1
Samples analysed in a laboratory setting
Total number of individuals tested is clearly stated for population-based studies (case reports and case series were categorised sep-
arately and did not need to meet this criterion)
Exclusion
criteria
Published before 1980
Primary focus on malaria, HIV, or tuberculosis
Non-clinical studies (descriptions of laboratory methods, modelling studies, economic evaluations, opinion pieces)
Drug or vaccine trial
Studies conducted in travellers
Other studies of disease not including laboratory identification of pathogens causing fever
1The definition of a confirmed diagnosis was restricted to pathogens detected in or cultured from samples from normally sterile sites (e.g. bacterial or fungal
isolates cultured from the blood, cerebrospinal fluid, arthrocentesis or paracentesis fluid, etc., or virus or parasite detection in the blood or cerebrospinal fluid) or
serological evidence of current or past infection
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risk, and those not clearly reporting the diagnostic
methods used at unclear risk (Additional file 3).
Results
Search results
The database search identified 16,523 records, of which
14,777 (89.4%) were in English and 1746 (10.6%) in
French. Additional 80 records were identified from the
bibliographies of other reports and through the personal
knowledge of the co-authors, bringing the total number of
articles identified to 16,603. Of the records resulting from
the initial search, 703 (4.2%) were identified as duplicates
and removed. Of the remaining 15,900 unique records, a
further 9715 (61.1%) were excluded after title and abstract
screening because they did not fit the selection criteria,
leaving 6185 papers for full-text screening. Additional
5120 publications were excluded after full-text assessment
bringing the total number of articles included in the re-
view to 1065 (Fig. 1). Of the 1065 publications, 472
(44.3%) were fever series, 412 (38.7%) were case series, 160
(15.0%) were seroprevalence studies, and 21 (2.0%) were
of mixed study designs (Additional file 2).
Spatial distribution
The geographical distribution of the sites in the included pa-
pers is shown in Fig. 2; 262 reports (24.6%) were from Eastern
Africa, 297 (27.9%) were from Western Africa, 238 (22.3%)
were from Northern Africa, 125 (11.7%) from Southern Af-
rica, 122 (11.5%) from Middle Africa, and 21 (2.0%) were
multi-regional. South Africa (n= 120, 11.3%), Nigeria (n=
113, 10.6%), and Tunisia (n= 76, 7.1%) contributed the most
reports. There were five or fewer articles from Benin, Burundi,
Libya, Namibia, Botswana, Comoros, Djibouti, Niger, Equator-
ial Guinea, and Swaziland (Fig. 3), with no reports from Cabo
Verde, Eritrea, Guinea-Bissau, Lesotho, Mauritius, Mauritania,
Sao Tome and Principe, and Seychelles.
The median distance between the study sites and the
nearest major city was 16.3 km (range 0.2–821.0 km), with
585 (72.5%) of 806 study sites being within a radius of
100 km and 392 (48.6%) of 806 sites being within a radius
of 20 km of the nearest major city (Additional file 3).
Study population
Neonates were reported on in 64 (6.0%) published arti-
cles, infants in 12 (1.1%), children aged 1 to < 13 years in
146 (13.7%), and older children and adults (≥ 13 years) in
Fig. 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram of publications screened in a systematic
review of published aetiological studies and case reports from Africa, 1980–2015
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224 (21.0%). Of all reports, 386 (36.2%) included all ages,
while age was not specified in 233 (21.9%) reports. The
age distribution for each geographical region is provided
in Additional file 1 (Section 2).
Samples collected and diagnostic methods
Blood was the main specimen analysed in 886 (83.2%) pub-
lished reports, reflecting our selection criteria. Cerebrospinal
fluid (CSF) samples were reported in 79 (7.4%) articles; a
combination of CSF and blood culture in 40 (3.8%); bone
marrow, joint, or liver aspirates in 13 (1.2%); multiple sam-
ple sources in 44 (4.1%); and the source was not stated in
three (0.3%) articles (Additional file 1, Section 2).
Bacterial infections were detected using culture methods
in 428 (75.9%) reports and serological assays in 111
(19.7%) reports. For viruses, 297 (79.4%) articles reported
serological testing and 70 (18.7%) used PCR (Additional
file 1, Section 2). Fungal infections were identified using
culture methods in eight of nine reports, while parasites
were detected using culture method in 20 (42.6%) and
serological method in 19 (40.4%) reports.
Additional file 2 presents laboratory methods used over
time to identify specific microorganism. For example, the
detection of Ebola virus was based on serological tests in
40 of 47 earlier study reports (1983–2005) while 17 out of
23 more recent studies used PCR (207–2015).
Aetiological findings
Bacterial infections were reported in 564 (53.0%) pub-
lished articles, viral infections in 374 (35.1%), parasitic
infections in 47 (4.4%), and fungal infections in nine
(0.8%). Of the 71 (6.7%) articles reporting multiple
groups, 46 (64.8%) reported bacteria and fungi; 21
(29.6%) reported bacteria and viruses; two (2.8%) re-
ported bacteria, viruses, and parasites; and two (2.8%) re-
ported bacteria, viruses, and fungi. The median (range)
number of pathogens reported in a study was one (1–
31) with 827 (77.7%) studies reporting four or fewer
pathogens and 82 (7.8%) reporting ≥ 10 pathogens. A list
of pathogens reported by country is presented in Add-
itional file 2.
Bacterial infections
Among 636 published reports of bacterial infections, the
most commonly reported were due to Staphylococcus
aureus (n = 194 reports), non-typhoidal Salmonella
(NTS) (n = 184), Escherichia coli (n = 164), and Strepto-
coccus pneumoniae (n = 149) (Fig. 4). Among children,
Streptococcus pneumoniae (n = 50), NTS (n = 49), and
Staphylococcus aureus (n = 46) were the most reported
isolates. Among infants, non-typhoidal Salmonella (n =
7), E. coli (n = 7), Streptococcus agalactiae (n = 6),
Staphylococcus aureus (n = 5), and Streptococcus pneu-
moniae (n = 5) were the five most commonly reported.
Among neonates, Klebsiella spp. including Klebsiella
pneumoniae (n = 60), Escherichia coli (n = 48), Staphylo-
coccus aureus (n = 41), and Streptococcus agalactiae (n =
25) were most reported. The overall distribution of arti-
cles by patient age and predominant mode of transmis-
sion is presented in Additional file 1, section 3.
Fig. 2 Location of study sites in a systematic review of published aetiological studies and case reports from Africa, 1980–2015. Legend: Location
of study sites reported on in this review (in blue) augmented with major cities (in red). Data on major cities were obtained from “maps” package
in R software, and for the purpose of this review, only cities with population greater than 100,000 are shown. Case series included individual case
reports or series of patients with the same condition. Studies were classed as fever series if the total population denominator tested was
reported. Seroprevalence studies were those where serum samples were tested for one pathogen or a panel of pathogens simultaneously
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Vector-borne bacterial infections
Rickettsial infections (n = 69 published reports) and tick-
and louse-borne relapsing fevers caused by Borrelia spp.
(n = 32) were the most commonly reported vector-borne
infections (Fig. 4 and Additional files 1 and 2). The pre-
dominant rickettsial species reported was Rickettsia con-
orii (n = 42), the cause of Mediterranean spotted fever,
which is transmitted by the dog tick and appears to have
a widespread distribution throughout the African contin-
ent. There were five reports of Borrelia recurrentis,
which is associated with relapsing fever, all from
Ethiopia. Among neonates, there was a single report of
Borrelia caucasica from Rwanda. There were no reports
of vector-borne infections among infants.
Food- and/or water-borne bacterial infections
Non-typhoidal Salmonella (n = 184 published reports)
was the leading cause of food- and water-borne bacterial
infections followed by typhoidal Salmonella (n = 76),
Brucella spp. (n = 21), Leptospira spp. (n = 14), and Shi-
gella spp. (n = 14). Infections due to Listeria spp., Aero-
monas spp., Cholera spp., and Campylobacter spp. were
infrequent and reported in fewer than 10 articles (Fig. 4,
and also see Additional file 2). Four cases of Burkhol-
deria pseudomallei were reported from Gabon,
Madagascar, and Malawi (see Additional file 2).
Bacterial infections that spread through contact
Staphylococcus aureus (n = 194 published reports),
Streptococcus pneumoniae (n = 149), Klebsiella spp. (n =
92), Klebsiella pneumonia (n = 80), and Enterobacter
spp. (n = 76) were the most commonly reported bacterial
infections in this category. E. coli (n = 48) was the most
commonly reported bacterium among neonates (n = 48)
and infants (n = 7), and Streptococcus pneumoniae (n =
50) among children aged 1 to < 13 years.
Air-borne bacterial infections
Coxiella spp. (n = 35 published reports) of which 31 were
due to Coxiella burnetii, Mycobacterium spp. (n = 2),
and Legionella spp. (n = 1) were the only predominantly
air-borne bacterial infections reported.
Viral infections
Among 415 published reports of viral infections, there
were none in infants, and only three in neonates
Fig. 3 The number of publications by country, in a systematic review of published aetiological studies and case reports from Africa, 1980–2015. Legend:
The total number of studies reported from each of the country over the review period from 1980 to 2015. Case series included individual case reports or
series of patients with the same condition. Studies were classed as fever series if the total population denominator tested was reported. Seroprevalence
studies were defined if serum samples were tested for one pathogen or a panel of pathogens simultaneously
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attributed to cytomegalovirus, enterovirus, and herpes
simplex virus once each (Additional file 2). The distribu-
tion of the most commonly reported viral infections is
presented in Fig. 5 and of viral haemorrhagic fevers
(VHFs) in Fig. 6.
Vector-borne viral infections
Yellow fever virus (n = 75 published reports) was the
most commonly reported arbovirus. Dengue virus
(DENV) serotypes 1 to 4 were reported in 54 articles
from 20 countries (Figs. 5 and 6), the majority of which
were published from 2010 through 2015 (61.1%, 33/54)
with serotype 2 being the most reported (n = 17). Chi-
kungunya virus was reported in 37 articles, the majority
from studies conducted in Eastern Africa (62.1%, 23/37)
(Fig. 7). Zika virus was reported in one article each from
Nigeria in 1983, Madagascar in 1989, Uganda in 1989,
Djibouti in 1996, and Gabon in 2014 (Additional file 2).
Food- and/or water-borne viral infections
Hepatitis A virus was reported in 11 studies from Egypt
(n = 6), Ghana (n = 1), Morocco (n = 2), South Africa
(n = 1), and Ivory Coast (n = 1). Hepatitis E was reported
in Egypt in three studies and in one study each from
Ethiopia, Ghana, Kenya, Somalia, and Sudan (Additional
file 2). Enteroviruses were reported in an article each
from Malawi, Morocco, Senegal, South Africa, and
Tunisia. Enteroviruses among neonates were reported in
the article from Morocco, among children from the
articles in South Africa and Tunisia, and among partici-
pants of all ages from Malawi and Senegal (Additional
file 2).
Air-borne viral infections
Measles virus was reported in eight articles in Nigeria
(n = 3), Sudan (n = 3), Ghana (n = 1), and Somalia (n =
1). Hantaan virus was reported in seven articles from
Cameroon, Central African Republic, Chad, Egypt,
Guinea, Equatorial Guinea, Gabon, Mauritania, and
Nigeria. Respiratory syncytial virus (RSV; n = 1) was re-
ported in an article from Egypt. No other air-borne vi-
ruses were reported.
Viral infections spreading through contact
Rift Valley fever virus (n = 79 published reports) was the
most common viral infection reported in this category.
Ebola virus disease (n = 71 reports) was the second most
common viral infection reported in this category, of
which 18 (25.3%) were published during the 2014–2016
West African outbreak. The other most frequently re-
ported viruses were Lassa virus (n = 35), Marburg virus
(n = 25), hepatitis B virus (n = 20), and hepatitis C virus
(n = 14) (Fig. 5).
Fungal infections
A list of all reported fungal infections, from 57 published
articles, is presented in Additional file 1 (Section 3).
Candida spp. were the most commonly reported causes
Fig. 4 The most commonly reported bacterial infections by mode of transmission, in a systematic review of published aetiological studies and case
reports from Africa, 1980–2015. Legend: The left-hand panel includes data from all study types (case series, fever series, and seroprevalence studies).
The right-hand panel is restricted to fever series data. The graph presents the top 10 pathogens (based on the number of the published articles) by
epidemiological mode of transmission. The numbers inside each dot represent the number of articles
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Fig. 5 The most commonly reported viral infections by mode of transmission, in a systematic review of published aetiological studies and case
reports from Africa, 1980–2015. Legend: The left panel includes data from all the study types (case series, fever series, and seroprevalence studies).
The right panel is restricted to the fever series data. The graph presents the top 10 pathogens (based on the number of the published articles) by
epidemiological mode of transmission. The numbers inside each dot represent the number of articles
Fig. 6 Viral haemorrhagic fever, in a systematic review of published aetiological studies and case reports from Africa, 1980–2015. Legend: CCHF
Crimean-Congo haemorrhagic fever virus. The map shows the location of study sites reporting each pathogen. No distinction has been made
between case series, fever series, and seroprevalence studies
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of fungal infections among neonates (n = 13 reports) and
children (n = 7). Cryptococcus spp. (n = 7) were com-
monly reported among adults and were reported in stud-
ies from Botswana, Malawi, and South Africa; of these,
two studies included some HIV-infected patients.
Parasitic infections
Among the 49 published articles reporting non-malaria
parasitic infections, leishmaniasis was the most commonly
reported (n = 28 reports) among both children (n = 7) and
adults (n = 8) (Additional file 1, Section 3). Leishmania
spp. were reported from Cameroon, Chad, Ivory Coast,
Ethiopia, Gambia, Morocco, Sierra Leone, Somalia, Sudan,
and Tunisia with the majority of articles being from
Tunisia (n = 11). Trypanosoma spp. (n = 4), Mansonella
perstans (n = 2), Wuchereria bancrofti (n = 2), and Babesia
spp. (n = 1) were the pathogens of the other vector-borne
parasitic infections. Fasciola hepatica, the common liver
fluke, was reported in three articles from Egypt, Schisto-
soma spp. in three articles from Egypt, Taenia spp. in an
article each from Egypt and South Africa, and Loa loa in
an article from Nigeria (Additional file 2). There were no
reports of parasitic infections among neonates and infants.
Spatial and temporal trends in infectious causes of fever
The most commonly reported fever-causing pathogens
in each of the geographical regions over the period of
this systematic review are presented in Tables 2, 3, 4, 5,
and 6 (see Additional file 1, Section 4 for further details).
Rift Valley fever (RVF) virus predominated in reports
from Eastern Africa (Table 2), and yellow fever virus,
RVF, and Lassa virus from Western Africa (Table 3). In
Northern Africa, RVF was the most commonly reported
virus until 2000, after which no reports were identified
(Table 4). Viruses causing haemorrhagic fever predomi-
nated in Middle African reports (Table 6). E. coli,
Staphylococcus aureus, typhoidal and non-typhoidal Sal-
monella, and Streptococcus pneumoniae were the most
commonly reported bacterial causes of fever in Eastern
and Western Africa throughout the study period (Tables
2 and 3).
Vaccine-preventable infections
Figure 8 presents the sites of studies reporting some
vaccine-preventable infections that are part of the WHO
routine Expanded Programme on Immunisation (EPI)
[23]. Infection with Haemophilus influenzae type b,
hepatitis B, measles, mumps, rubella, yellow fever, and
invasive infections caused by Neisseria meningitidis or
Streptococcus pneumoniae are all reported, with an in-
creasing number of publications on the latter two organ-
isms over time. There was only one report of
Corynebacterium diphtheriae from South Africa among
adults, and there were no reports of pertussis or tetanus.
Fig. 7 Reports of dengue, chikungunya, and Zika viral infections, a systematic review of published aetiological studies and case reports from
Africa, 1980–2015. Legend: DENV dengue virus, ZIKV Zika virus. For DENV, serotypes were not reported in 35 publications. The map shows the
location of study sites reporting each pathogen. No distinction has been made between case series, fever series, and seroprevalence studies
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Table 2 The top five most commonly reported pathogens in Eastern Africa, stratified by time period
1980 to≤ 1990 1991 to≤ 2000 2001 to≤ 2010 2011 to ≤ 2015
Bacteria Typhoidal Salmonella (n = 5) Streptococcus pneumoniae (n = 7) Non-typhoidal Salmonella (n = 30) Staphylococcus aureus (n = 29)
Non-typhoidal Salmonella (n = 4) Staphylococcus aureus (n = 7) Streptococcus pneumoniae (n = 24) Non-typhoidal Salmonella (n = 28)
Borrelia spp. (n = 4) Escherichia coli (n = 7) Staphylococcus aureus (n = 22) Escherichia coli (n = 23)
Staphylococcus aureus (n = 3) Rickettsia typhi (n = 5) Escherichia coli (n = 22) Streptococcus pneumoniae (n = 20)
Streptococcus pneumoniae (n = 2) Haemophilus spp. (n = 5) Haemophilus spp. (n = 20) Klebsiella spp. (n = 13)
Viruses Rift Valley fever virus (n = 6) Rift Valley fever virus (n = 9) Ebola virus (n = 9) Dengue virus (n = 13)
Ebola virus (n = 5) Yellow fever virus (n = 5) Rift Valley fever virus (n = 7) Chikungunya virus (n = 12)
Chikungunya virus (n = 5) O’nyong-nyong virus (n = 3) Chikungunya virus (n = 4) Rift Valley fever virus (n = 11)
Wesselsbron virus (n = 4) West Nile virus (n = 2) Marburg virus (n = 2) Yellow fever virus (n = 9)
CCHF virus (n = 3) CCHF virus (n = 2) Dengue virus (n = 2) West Nile virus (n = 4)
Parasites Family Trypanosomatidae (n = 1) Toxocara spp. (n = 1) Wuchereria bancrofti (n = 1) Leishmania spp. (n = 1)
– – Trypanosoma spp. (n = 1) Babesia spp. (n = 1)
– – Leishmania spp. (n = 1) –
Fungi Cryptococcus spp. (n = 1) Candida albicans (n = 2) Cryptococcus spp. (n = 2) Cryptococcus spp. (n = 3)
– Candida spp. (n = 1) Fungus (n = 1) Candida spp. (n = 2)
– – Candida spp. (n = 1) –
CCHF Crimean-Congo haemorrhagic fever virus. No distinction has been made between case series, fever series, and seroprevalence studies. Numbers in
parenthesis indicate the number of publications reporting the given microorganism. The complete list of the microorganisms reported in a given region and time
period is provided in Additional file 2
Table 3 The top five most commonly reported pathogens in Western Africa, stratified by time period
1980 to≤ 1990 1991 to≤ 2000 2001 to≤ 2010 2011 to≤ 2015
Bacteria Staphylococcus aureus (n = 7) Staphylococcus aureus (n = 11) Staphylococcus aureus (n = 20) Staphylococcus aureus (n = 22)
Typhoidal Salmonella (n = 5) Streptococcus pneumoniae (n = 9) Streptococcus pneumoniae (n = 16) Escherichia coli (n = 21)
Klebsiella spp. (n = 4) Non-typhoidal Salmonella (n = 8) Escherichia coli (n = 16) Streptococcus pneumoniae (n = 16)
Citrobacter spp. (n = 4) Neisseria meningitidis (n = 7) Klebsiella spp. (n = 11) Klebsiella spp. (n = 13)
Non-typhoidal Salmonella (n = 4) Escherichia coli (n = 5) Streptococcus spp. (n = 10) Klebsiella pneumoniae (n = 12)
Viruses Yellow fever virus (n = 14) Yellow fever virus (n = 11) Yellow fever virus (n = 11) Ebola virus (n = 15)
Lassa virus (n = 12) Rift Valley fever virus (n = 3) Lassa virus (n = 6) Lassa virus (n = 11)
Rift Valley fever virus (n = 8) Lassa virus (n = 2) Rift Valley fever virus (n = 4) Rift Valley fever virus (n = 7)
CCHF virus (n = 7) Measles virus (n = 1) CCHF virus (n = 2) Dengue virus (n = 7)
Chikungunya virus (n = 3) CCHF virus (n = 1) Dengue virus (n = 2) Yellow fever virus (n = 5)
Parasites Loa loa (n = 1) Leishmania spp. (n = 1) Trypanosoma spp. (n = 1) Wuchereria bancrofti (n = 1)
Leishmania spp. (n = 1) – Leishmania spp. (n = 1) Mansonella perstans (n = 1)
Fungi – Candida spp. (n = 1) – Candida spp. (n = 2)
– Candida albicans (n = 1) – Penicillium spp. (n = 1)
– – – Cryptococcus spp. (n = 1)
– – – Candida albicans (n = 1)
– – – Aspergillus niger (n = 1)
CCHF Crimean-Congo haemorrhagic fever virus. No distinction has been made between case series, fever series, and seroprevalence studies. Numbers in
parentheses indicate the number of publications reporting the given microorganism. The complete list of the microorganisms reported in a given region and time
period is provided in Additional file 2
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Assessment of risk of bias
Among 1065 articles, the risk of bias was considered to
be high in 426 articles (40.0%), moderate in 322 (30.2%),
and low in 305 (28.6%). In the remaining 12 (1.1%) arti-
cles, the risk of bias was unclear (Additional file 3, Sec-
tion 1). There was a reporting bias toward urban settings
(Additional file 3, Section 2).
Discussion
In Africa, the causes of non-malarial febrile illness and
the distributions of associated pathogens are poorly
understood due to the lack of aetiological testing [5, 10,
24]. As malaria is less prevalent than previously thought,
and declining further in some areas, understanding the
aetiology of fever is an increasingly important public
health challenge [25, 26]. Management of non-malarial
febrile illness in resource-constrained settings poses a
conundrum to patients and health workers, who are
often compelled to use antimicrobials empirically [27].
In addition to inappropriately treating individual pa-
tients, antimicrobial prescribing may be an important
driver of antimicrobial drug resistance. To characterise
the spectrum of causative pathogens for non-malarial fe-
brile illnesses in Africa, a systematic review of published
literature, to our knowledge the largest on this topic,
was undertaken.
This review makes several observations that are highly
relevant from a public health perspective. It demon-
strates a broad diversity and heterogeneity of informa-
tion reported about patient populations, laboratory
methods, quality assurance of laboratory standards, and
the wide spectrum of microorganisms detected and
identified. This observation expands on similar findings
in a narrative review of recent studies of NMFI in Africa
[28]. This review also reveals heterogeneous and often
poor reporting of study population ages, with 21.9% of ar-
ticles not mentioning the age range of patients tested, des-
pite this information being essential to interpret clinical
and epidemiological studies, and to guide policy decisions.
Over a third of the identified studies were published from
2010 to 2015, a time period after the introduction of the
“test before treat” approach for the case management of
malaria. This illustrates a recent heightened interest in
identifying the causes of febrile illnesses. Just over 70% of
the study sites were located in urban centres or within a
radius of 100 km from the nearest city. While urbanisation
is increasing globally, as of 2018, the United Nations esti-
mated that Africa remains mostly rural with just 43% of
the population living in urban areas [29]; so this reporting
bias represents a substantial knowledge gap for causes of
fever in rural environments.
Bacterial or viral infections were the most commonly re-
ported pathogen groups, together constituting more than
80% of the articles included in this review. In children,
Streptococcus pneumoniae, Staphylococcus aureus, and
Salmonella enterica were commonly reported while Kleb-
siella spp., Escherichia coli, Staphylococcus aureus, and
Streptococcus agalactiae were the most reported isolates
in the neonatal age group. Vaccine-preventable infections
that are part of the routine EPI continue to be reported,
Table 4 The top five most commonly reported pathogens in Northern Africa, stratified by time period
1980 to≤ 1990 1991 to≤ 2000 2001 to ≤ 2010 2011 to≤ 2015
Bacteria Non-typhoidal Salmonella (n = 3) Coxiella burnetii (n = 7) Staphylococcus aureus (n = 22) Escherichia coli (n = 18)
Rickettsia conorii (n = 3) Non-typhoidal Salmonella (n = 5) Escherichia coli (n = 14) Klebsiella pneumoniae (n = 13)
Neisseria meningitidis (n = 3) Rickettsia conorii (n = 5) Rickettsia conorii (n = 11) Staphylococcus aureus (n = 10)
Streptococcus pneumoniae (n = 2) Rickettsia typhi (n = 4) Pseudomonas aeruginosa (n = 11) Staphylococcus, coagulase negative (n = 9)
Typhoidal Salmonella (n = 2) Streptococcus pneumoniae (n = 3) Streptococcus spp. (n = 9) Streptococcus pneumoniae (n = 7)
Viruses Rift Valley fever virus (n = 3) Rift Valley fever virus (n = 6) Hepatitis C virus (n = 3) Dengue virus (n = 8)
Hepatitis B virus (n = 2) West Nile virus (n = 3) Hepatitis B virus (n = 3) Yellow fever virus (n = 6)
Hepatitis A virus (n = 2) Sandfly fever Sicilian virus (n = 3) Hepatitis A virus (n = 3) Hepatitis C virus (n = 5)
West Nile virus (n = 1) Sandfly fever Naples virus (n = 3) West Nile virus (n = 2) West Nile virus (n = 3)
Sandfly fever Naples virus (n = 1) Hantaan virus (n = 2) Dengue virus (n = 2) Toscana virus (n = 3)
Parasites – Leishmania spp. (n = 8) Leishmania spp. (n = 7) Leishmania spp. (n = 6)
– Fasciola hepatica (n = 3) – Schistosoma spp. (n = 2)
– Toxoplasma spp. (n = 1) – –
– Toxocara spp. (n = 1) – –
– Taenia spp. (n = 1) – –
Fungi – Aspergillus fumigatus (n = 2) Candida albicans (n = 4) Candida spp. (n = 5)
– Candida spp. (n = 1) Candida spp. (n = 3) Candida albicans (n = 4)
– Candida albicans (n = 1) Penicillium marneffei (n = 1) Candida parapsilosis (n = 2)
– – Mucor spp. (n = 1) Candida ciferrii (n = 2)
– – Histoplasma (n = 1) Blastoschizomyces pseudotrichosporon (n = 2)
No distinction has been made between case series, fever series, and seroprevalence studies. Numbers in parenthesis indicate the number of publications
reporting the given microorganism. The complete list of the microorganisms reported in a given region and time period is provided in Additional file 2
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although there was no report of pertussis, which is com-
mon in Africa [30]; the absence of reports in this review
may be explained both by the exclusion of respiratory spe-
cimen testing and by the absence of accessible diagnostics.
Most of the bacterial pathogens reported are well
known and common in countries at all income levels
(Table 7). However, there were some exceptions. For
example, there were only four reported cases of Burkhol-
deria pseudomallei, from Madagascar, Malawi, and
Gabon. B. pseudomallei is notoriously easy to miss in
the clinical microbiology laboratory if the index of suspi-
cion is low and it is not specifically sought. A recent
modelling study has predicted the disease to be endemic
and under-reported in much of sub-Saharan Africa [31],
Fig. 8 Studies reporting vaccine-preventable infections which are part of the WHO routine Expanded Programme on Immunisation, in a
systematic review of published aetiological studies and case reports from Africa, 1980–2015. Legend: The map shows the location of study sites
reporting each pathogen. No distinction has been made between case series, fever series, and seroprevalence studies
Table 6 The top five most commonly reported pathogens in Middle Africa, stratified by time period
1980 to ≤ 1990 1991 to≤ 2000 2001 to≤ 2010 2011 to≤ 2015
Bacteria Non-typhoidal Salmonella (n = 5) Non-typhoidal Salmonella (n = 5) Non-typhoidal Salmonella (n = 5) Staphylococcus aureus (n = 8)
Pseudomonas spp. (n = 2) Streptococcus pneumoniae (n = 3) Streptococcus pneumoniae (n = 5) Non-typhoidal Salmonella (n = 7)
Klebsiella pneumoniae (n = 2) Rickettsia conorii (n = 3) Neisseria meningitidis (n = 4) Escherichia coli (n = 6)
Escherichia coli (n = 2) Neisseria meningitidis (n = 3) Haemophilus spp. (n = 3) Streptococcus pneumoniae (n = 4)
Enterobacter spp. (n = 2) Coxiella burnetii (n = 2) Escherichia coli (n = 3) Enterobacter spp. (n = 4)
Viruses Ebola virus (n = 6) Ebola virus (n = 12) Ebola virus (n = 9) Yellow fever virus (n = 6)
Rift Valley fever virus (n = 5) Marburg virus (n = 6) Marburg virus (n = 8) Ebola virus (n = 4)
Yellow fever virus (n = 3) Hepatitis B virus (n = 2) Yellow fever virus (n = 5) Dengue virus (n = 3)
Marburg virus (n = 2) Saint-Floris virus (n = 1) West Nile virus (n = 3) Chikungunya virus (n = 2)
Lassa virus (n = 2) Rift Valley Fever virus (n-1) Dengue virus (n = 3) West Nile virus (n = 1)
Parasites – Trypanosoma spp. (n = 1) Entamoeba histolytica (n = 1) Trypanosoma spp. (n = 1)
– Leishmania spp. (n = 1) – Mansonella perstans (n = 1)
– – – Leishmania spp. (n = 1)
No distinction has been made between case series, fever series, and seroprevalence studies. Numbers in parenthesis indicate the number of publications
reporting the given microorganism. There were no data on fungal infections in Middle Africa
Elven et al. BMC Medicine          (2020) 18:279 Page 13 of 17
Ta
b
le
7
C
om
m
on
ly
re
po
rt
ed
ba
ct
er
ia
lp
at
ho
ge
ns
am
on
g
ne
on
at
es
,s
tr
at
ifi
ed
by
re
gi
on
an
d
tim
e
pe
rio
d
19
80
to
≤
19
90
19
91
to
≤
20
00
20
01
to
≤
20
10
20
11
to
≤
20
15
Re
g
io
n
Ea
st
er
n
Bo
rr
el
ia
ca
uc
as
ic
a
(n
=
1)
St
ap
hy
lo
co
cc
us
au
re
us
(n
=
3)
St
re
pt
oc
oc
cu
s
ag
al
ac
tia
e
(n
=
6)
St
ap
hy
lo
co
cc
us
au
re
us
(n
=
6)
–
Es
ch
er
ic
hi
a
co
li
(n
=
3)
Es
ch
er
ic
hi
a
co
li
(n
=
6)
Es
ch
er
ic
hi
a
co
li
(n
=
6)
–
St
re
pt
oc
oc
cu
s
ag
al
ac
tia
e
(n
=
2)
St
ap
hy
lo
co
cc
us
au
re
us
(n
=
5)
St
ap
hy
lo
co
cc
us
,c
oa
gu
la
se
ne
ga
tiv
e
(n
=
5)
–
Kl
eb
sie
lla
sp
p.
(n
=
2)
N
on
-t
yp
ho
id
al
Sa
lm
on
el
la
(n
=
5)
Kl
eb
sie
lla
sp
p.
(n
=
5)
–
En
te
ro
ba
ct
er
sp
p.
(n
=
2)
St
re
pt
oc
oc
cu
s
pn
eu
m
on
ia
e
(n
=
4)
St
re
pt
oc
oc
cu
s
sp
p.
(n
=
4)
W
es
te
rn
Ci
tr
ob
ac
te
r
sp
p.
(n
=
3)
St
re
pt
oc
oc
cu
s
sp
p.
(n
=
2)
St
ap
hy
lo
co
cc
us
au
re
us
(n
=
7)
Es
ch
er
ic
hi
a
co
li
(n
=
7)
St
re
pt
oc
oc
cu
s
sp
p.
(n
=
2)
St
ap
hy
lo
co
cc
us
au
re
us
(n
=
2)
Es
ch
er
ic
hi
a
co
li
(n
=
5)
St
ap
hy
lo
co
cc
us
au
re
us
(n
=
5)
St
re
pt
oc
oc
cu
s
pn
eu
m
on
ia
e
(n
=
2)
Pr
ot
eu
s
sp
p.
(n
=
2)
St
re
pt
oc
oc
cu
s
sp
p.
(n
=
4)
Ps
eu
do
m
on
as
ae
ru
gi
no
sa
(n
=
5)
St
re
pt
oc
oc
cu
s
ag
al
ac
tia
e
(n
=
2)
Kl
eb
sie
lla
sp
p.
(n
=
2)
St
ap
hy
lo
co
cc
us
sp
p.
(n
=
4)
N
on
-t
yp
ho
id
al
Sa
lm
on
el
la
(n
=
5)
St
ap
hy
lo
co
cc
us
au
re
us
(n
=
2)
Es
ch
er
ic
hi
a
co
li
(n
=
2)
Ps
eu
do
m
on
as
sp
p.
(n
=
4)
Kl
eb
sie
lla
pn
eu
m
on
ia
e
(n
=
5)
N
or
th
er
n
–
N
on
-t
yp
ho
id
al
Sa
lm
on
el
la
(n
=
2)
St
ap
hy
lo
co
cc
us
,c
oa
gu
la
se
ne
ga
tiv
e
(n
=
2)
Es
ch
er
ic
hi
a
co
li
(n
=
12
)
–
St
ap
hy
lo
co
cc
us
au
re
us
(n
=
1)
Se
rr
at
ia
liq
ue
fa
ci
en
s
(n
=
2)
Kl
eb
sie
lla
pn
eu
m
on
ia
e
(n
=
7)
–
Se
rr
at
ia
sp
p.
(n
=
1)
St
ap
hy
lo
co
cc
us
au
re
us
(n
=
1)
St
ap
hy
lo
co
cc
us
,c
oa
gu
la
se
ne
ga
tiv
e
(n
=
6)
–
Ps
eu
do
m
on
as
sp
p.
(n
=
1)
Se
rr
at
ia
m
ar
ce
sc
en
s
(n
=
1)
St
ap
hy
lo
co
cc
us
au
re
us
(n
=
6)
–
Kl
eb
sie
lla
sp
p.
(n
=
1)
Ps
eu
do
m
on
as
sp
p.
(n
=
1)
Kl
eb
sie
lla
sp
p.
(n
=
6)
So
ut
he
rn
Vi
br
io
ch
ol
er
ae
(n
=
1)
Ty
ph
oi
da
lS
al
m
on
el
la
(n
=
1)
St
re
pt
oc
oc
cu
s
pn
eu
m
on
ia
e
(n
=
1)
Es
ch
er
ic
hi
a
co
li
(n
=
4)
Ac
in
et
ob
ac
te
r
ca
lc
oa
ce
tic
us
(n
=
1)
Kl
eb
sie
lla
sp
p.
(n
=
1)
Pa
st
eu
re
lla
m
ul
to
ci
da
(n
=
1)
St
re
pt
oc
oc
cu
s
ag
al
ac
tia
e
(n
=
3)
–
–
Kl
eb
sie
lla
pn
eu
m
on
ia
e
(n
=
1)
St
ap
hy
lo
co
cc
us
au
re
us
(n
=
3)
–
–
En
te
ro
ba
ct
er
cl
oa
ca
e
(n
=
1)
Kl
eb
sie
lla
pn
eu
m
on
ia
e
(n
=
3)
–
–
–
St
re
pt
oc
oc
cu
s
pn
eu
m
on
ia
e
(n
=
2)
M
id
dl
e
–
–
St
re
pt
oc
oc
cu
s
pn
eu
m
on
ia
e
(n
=
1)
–
–
–
St
re
pt
oc
oc
cu
s
ag
al
ac
tia
e
(n
=
1)
–
–
–
Kl
eb
sie
lla
pn
eu
m
on
ia
e
(n
=
1)
–
N
o
di
st
in
ct
io
n
ha
s
be
en
m
ad
e
be
tw
ee
n
ca
se
se
rie
s,
fe
ve
r
se
rie
s,
an
d
se
ro
pr
ev
al
en
ce
st
ud
ie
s.
N
um
be
rs
in
pa
re
nt
he
si
s
in
di
ca
te
th
e
nu
m
be
r
of
pu
bl
ic
at
io
ns
re
po
rt
in
g
th
e
gi
ve
n
m
ic
ro
or
ga
ni
sm
Elven et al. BMC Medicine          (2020) 18:279 Page 14 of 17
a result consistent with the environmental surveys [32,
33]. Taken together, they provide evidence that this ser-
ious infection is being under-diagnosed in Africa. The
reports of Klebsiella spp. as a common causative agent
of neonatal sepsis are noteworthy, given the intrinsic re-
sistance of this pathogen to amoxicillin, the empiric
treatment (with gentamicin) for neonatal sepsis in many
LMICs. Other studies over the last decade have sug-
gested that Klebsiella is being diagnosed more frequently
than before in early onset neonatal sepsis [34, 35].
The literature on viral infections was heavily biased to-
ward the more lethal viral haemorrhagic fevers reflecting
the attention that outbreaks of these diseases attract glo-
bally. The 2014–2016 West African outbreak was associ-
ated with a spike in the number of publications on Ebola
virus disease, accounting for nearly a quarter of the
Ebola virus disease reports published during the period
of this review. There were only five reports of Enterovi-
ruses, specifically coxsackie B3 virus, from the whole of
Africa which contrasts with multiple descriptions of
Enterovirus-71 outbreaks reported in Asia [31]. Dengue
fever has not received much attention in Africa com-
pared to malaria, despite the virus being present in most
regions of the continent. Before the 1980s, there were no
confirmed cases of dengue virus disease in Africa [31],
and the number of reports identified in this review sug-
gests that either the disease is increasingly endemic or
the pathogen increasingly sought. Accurate point-of-care
tests for dengue based on combined IgM antibody and
NS1 antigen detection are now available, and they could
be considered for incorporation into fever case manage-
ment algorithms [24]. Viral hepatitis, whose burden has
increased globally over the past 30 years [36], was re-
ported from 18 countries with the majority of the arti-
cles being from Egypt.
This review has several limitations. First, as stated, the
data presented here reflect neither overall incidence nor
the prevalence of the microorganisms and should not be
over-interpreted. That a pathogen was not reported from
a country or region cannot be taken as definitive evi-
dence of its absence, because this review did not capture
records of an organism being sought but not found. Re-
searchers are likely to look for pathogens that have been
previously recognised or reported, or in order to answer
a specific research question, such as on vaccine protect-
ive efficacy for a particular pathogen, or management of
outbreaks (e.g. Ebola virus). It is worth noting that while
malaria was reported across the entire African continent
in the early 1980s, some northern and far southern re-
gions have now eliminated the disease; this review did
not exclude malaria-free countries. Reports on the pres-
ence of newsworthy pathogens, such as Ebola virus and
Zika virus, are also more likely to be published, and thus,
the clinical literature is susceptible to substantial
reporting biases. Under-reporting is further com-
pounded by the fact that some patients might have taken
antimicrobials prior to hospital presentation, masking
some bacterial pathogens. Nucleic acid amplification
tests can also lack sensitivity for some infections, such as
when timing of collection is after the bacteraemia or
viremia has peaked. Routine data from clinical speci-
mens tested in hospitals and private laboratories would
provide a more representative picture of the leading
causes of non-malaria febrile illness, but these are pub-
lished infrequently. Increased electronic laboratory and
clinical data capture has the potential to transform rou-
tine disease surveillance and information sharing in the
future. Restricting the search to pathogens detected in
blood and CSF meant that some important or common
infections such as helminths and respiratory and sexually
transmitted infections were omitted. However, restric-
tion to organisms isolated from normally sterile sites
limits the potential for misinterpretation of pathogen
data in terms of distinguishing colonisation from true
infection.
The studies included in this review exhibited large het-
erogeneity of study design, patient population, and diag-
nostic assays used. It was not feasible to
comprehensively assess the heterogeneity of case defini-
tions, or the quality of various study elements, because
of inconsistent reporting and varied laboratory and diag-
nostic techniques. Just over two-third of the studies in-
cluded in this review were considered to be at moderate
to high risk of bias (Additional file 3). This heterogeneity
precludes the possibility of any meaningful amalgam-
ation of the data and meta-analysis. However, such ana-
lysis may be pursued in the future for subsets of studies
identified through the database, which is publicly avail-
able on-line [20]. Information on the origin of the infec-
tions, including whether community- or hospital-
acquired, was not systematically reported in the articles.
Such information is particularly important in the assess-
ment of the burden of antimicrobial resistance, since in-
fections acquired in health care settings are more often
drug resistant. Further limitation of this review is that
information regarding whether the data originated from
the referral facilities—where sicker patients are treated—
or from the primary care level—where most people in
SSA seek care was not available. There is a need for
standardisation of the design and reporting of studies of
the epidemiology of febrile illness, to aid comparison
through time and space.
Certain pathogens are more likely to be hospital-
acquired, such as Candida spp. and some Gram-
negative bacteria such as Acinetobacter baumannii. The
latter was reported from all regions except Western Af-
rica; of note, this predominantly nosocomial infection
has been associated with a high case fatality risk of 41%
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in hospitalised patients in Thailand [37]. The Global
Antimicrobial Resistance Surveillance System (GLASS)
has standardised the definition of nosocomial infections,
and infection source should be clearly identified in fu-
ture reports [38]. This review did not systematically cap-
ture whether the seroprevalence studies reported
evidence of current or very recent infection (IgM, or
change in antibody titre) or past infection (IgG). Finally,
information regarding the underlying antimicrobial sus-
ceptibilities of pathogens was not reported in this review.
A subset of the articles included in this review provided
antimicrobial resistance data, which is currently being
extracted and will be reported in the future.
Conclusions
This review provides a comprehensive summary of pub-
lished reports on potential causes of non-malarial febrile
illnesses in Africa. Pathogens and diseases previously
under-recognised or not thought to be endemic on the
continent are clearly present, including dengue virus and
melioidosis. Testing and reporting of febrile disease aeti-
ology in Africa is patchy, with probably substantial
under-reporting of and under-consideration of import-
ant pathogens in many regions. Reporting of microbiol-
ogy data needs to improve, including classifying bacterial
infections as community- or hospital-acquired. This con-
cern has been noted by other authors and is an impedi-
ment to current assessments of the burden of drug-
resistant infections in LMICs [39]. Guidelines for report-
ing fever aetiology studies are vital to improve the public
health value of such research. More emphasis is needed
in rural areas that remain beyond the reach of many re-
search and surveillance efforts. A mechanism such as
the recently inaugurated African Centers for Disease
Control and Prevention may be able to reform this area.
As the threat of antimicrobial resistance looms large,
knowledge of the distribution of pathogens causing fe-
brile illness should facilitate priority setting in the devel-
opment of new diagnostic tools and improved
antimicrobial stewardship.
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